The effectiveness of this treatment has been highlighted in several clinical trials, including one study where participants experienced an average weight loss of 15.2% of their body weight, compared to 2.6% in the placebo group
First-in-human phase 1 study to assess safety, tolerability, and pharmacokinetics of a novel antifungal drug, VL-2397, in healthy adults
The body converts cyanocobalamin into its active forms (methylcobalamin and adenosylcobalamin) after absorption
While MYC is a well-characterized human oncogene, systemic suppression of MYC as a targeted human longevity intervention is currently unproven and remains confined to transgenic mouse models and in vitro assays
In addition, it was shown that there is an increase in IRS-1 phosphorylation on Ser636 and Ser639
BPC-157 is being investigated for its potential to accelerate tissue repair, ease chronic inflammation, and enhance recovery in both musculoskeletal and gut-related conditions
